Palbociclib, Trastuzumab, Lapatinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Conditions: Breast Cancer; Brain Metastases Intervention: Drug: Palbociclib, Trastuzumab, Lapatinib and Fulvestrant Sponsor: wang shusen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | China Health | Herceptin | Neurology | Research | Study